Anais
Anais Bialy, Hofheim DE
Patent application number | Description | Published |
---|---|---|
20090317647 | Coloured Aqueous Polymer Dispersions, And Production And Use Of Same - The invention relates to a coloured polymer dispersion containing, as main ingredients: (a) a coloured polymer produced by polymerisation of monomer A with monomer B, monomer A being a pigment B which is coated with a polymerisable wax D wherein the polymerisable function is an ethylenically unsaturated group, monomer B being a ethylenically unsaturated compound; (b) at least one non-ionic surface-active additive E based on polyethers and/or polyglycerines; (c) at least one anionic surface-active additive F based on sulfonates, sulfates, phosphonates, phosphates or carboxylates; and (d) water. | 12-24-2009 |
20120171604 | Coloured Aqueous Polymer Dispersions, And Production And Use Of Same - The invention relates to a coloured polymer dispersion containing, as main ingredients: (a) a coloured polymer produced by polymerisation of monomer A with monomer B, monomer A being a pigment B which is coated with a polymerisable wax D wherein the polymerisable function is an ethylenically unsaturated group, monomer B being a ethylenically unsaturated compound; (b) at least one non-ionic surface-active additive E based on polyethers and/or polyglycerines; (c) at least one anionic surface-active additive F based on sulfonates, sulfates, phosphonates, phosphates or carboxylates; and (d) water. | 07-05-2012 |
Anais Fournial, Renaze FR
Patent application number | Description | Published |
---|---|---|
20110152289 | DIMERIC DERIVATIVES OF ARTEMISININ AND APPLICATION IN ANTI-CANCER THERAPY - The present invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin of formula (I) below: Formula (I) and the pharmaceutically acceptable salts thereof, and also to the preparation method thereof and to the uses thereof, especially in the treatment of cancer. | 06-23-2011 |
Anais Girard-Gagnepain, Lyon FR
Patent application number | Description | Published |
---|---|---|
20140235700 | LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS - The present invention concerns a pseudotyped viral vector particle for transferring biological material into cells, wherein said vector particle comprises at least:—a chimeric envelope glycoprotein which comprises or consists in a fusion of the transmembrane and extracellular domain of a baboon endogenous retrovirus (BaEV) envelope glycoprotein and the cytoplasmic tail domain of a murine leukemia virus (MLV) envelope glycoprotein; or—a modified BaEV envelope glycoprotein wherein the cytoplasmic tail domain is devoid of the fusion inhibitory R peptide. | 08-21-2014 |
Anais Legent, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20120167237 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 06-28-2012 |
20120204278 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human—non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 08-09-2012 |
20130042331 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 02-14-2013 |
20130318643 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 11-28-2013 |
20140120582 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 05-01-2014 |
20140134156 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 05-15-2014 |
20140150125 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human—non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 05-29-2014 |
20140150126 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 05-29-2014 |
20140182003 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human—non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 06-26-2014 |
20140201854 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 07-17-2014 |
20140201856 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 07-17-2014 |
20160044900 | ANIMAL MODELS AND THERAPEUTIC MOLECULES - The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods. | 02-18-2016 |
Anais Prats Capote, La Habana CU
Patent application number | Description | Published |
---|---|---|
20160106691 | CHEMICAL CHAPERONINS AS NOVEL MOLECULAR MODULATORS OF BETA PROTEIN AGGREGATION PRESENT IN CONFORMATIONAL DISEASES - This invention relates to chemistry and biochemistry applied to the field of medicine and is referred to a new method of prevention and therapeutic treatment of conformational diseases (CD), in particular to amyloid origin diseases by administrating an effective amount of one or more compounds, salts, prodrugs or solvates, which are considered herein as chemical chaperonins, of Formula I, | 04-21-2016 |
Anais Prats Capote, Habana CU
Patent application number | Description | Published |
---|---|---|
20150217005 | METHOD FOR OBTAINING NOVEL DERIVATIVES OF NAPHTHALENE FOR THE IN VIVO DIAGNOSIS OF ALZHEIMER'S DISEASE - This invention relates to a chemistry branch, particularly to the field of compounds' organic synthesis that belong to the aromatic bicyclic or naphthalene category, used in the detection of amyloid sheets. These new naphthalene derivatives have a general formula: Wherein R represents mutually independent groups. In I: R | 08-06-2015 |
Anais Sandamiani, Nice FR
Patent application number | Description | Published |
---|---|---|
20150242959 | AUTOMATIC AUDITING SYSTEM INCLUDING AGENCY DEBIT MEMO GENERATION - Methods, systems, and computer program products for auditing transactions involving sales of tickets by one business entity for a travel product provided by another business entity. An application receives data including a fare basis and a fare charged for a ticket. A plurality of priceable units each consistent with an itinerary of the ticket and each including a fare corresponding to the fare basis is determined. Combinations of these priceable units that conform to the itinerary are defined, and a fare for each combination determined. The fare of each combination is compared to the fare charged for the ticket, and a matching fare selected. The rules used to price the selected combination are compared to the ticket and pricing context of the ticket, and errors in pricing the ticket determined based thereon. An agency debit memo may be defined based on errors in pricing the ticket and audit discrepancies. | 08-27-2015 |
20160048926 | AUDITING SYSTEM WITH HISTORIC SALE DEVIATION DATABASE - Methods, systems, and computer program products for auditing of transactions involving the sale of travel services by an indirect seller. An auditing module receives data defining a transaction proposed by the indirect seller. The module compares a quoted price for the transaction to a correct price for the transaction to determine if there is a pricing discrepancy. If a discrepancy exists, the module classifies the transaction and searches a business rules database maintained by a travel service provider for business rules relevant to the classification. The audit module further queries a historical sales deviation database to retrieve seller history data, and selects the relevant business rule having the best match to the seller history data. The audit module then determines whether to allow or block the transaction, issue a warning, or suggest an Agency Debit Memo based on an action defined by the business rule having the best match. | 02-18-2016 |
Anaïs Ali Cherif, Paris FR
Patent application number | Description | Published |
---|---|---|
20140342373 | MICROFLUIDIC SYSTEM - The present invention concerns a microfluidic system comprising: a microchannel containing several elements of two non-miscible fluids, the microchannel comprising a droplet ( | 11-20-2014 |
Anaïs Ardan, Mons FR
Patent application number | Description | Published |
---|---|---|
20150088453 | DEVICE AND METHOD FOR DETERMINING THE ATTITUDE OF A SATELLITE, AND SATELLITE CARRYING SUCH A DEVICE - A device for determining the attitude or variation in attitude of a satellite fitted with an attitude control system comprising at least one inertial actuator. The inertial actuator comprises a rotary element mounted to rotate about an axis of rotation. The rotation of the rotary element is controlled to generate a torque to control controlling the attitude of the satellite. The angular sensor of the device measures the angular rotation of the rotary element about its axis of rotation. The computation unit determines the attitude or variation in attitude of the satellite induced by the rotation of the rotary element as a function of the measurements of angular rotation of the rotary element by the angular sensor. A satellite carrying such a device and a method for determining the attitude or variation in attitude. | 03-26-2015 |
Anaïs Bezacier-Mahiet, Crest FR
Patent application number | Description | Published |
---|---|---|
20100021406 | PROCESS FOR MAKING UP KERATIN FIBRES AND PACKAGING ASSEMBLY - The present invention relates to a cosmetic process for making up or for the non-therapeutic care of keratin fibres, comprising the application to the keratin fibres of a cosmetic composition containing at least one compound or a mixture of compounds, which, when the composition is brought to a temperature of greater than or equal to 40° C., confers on said composition a threading nature dmax of greater than or equal to 5 mm, said composition being, prior to, simultaneously with or subsequent to its application, brought to a temperature of greater than or equal to 40° C. The invention also relates to a packaging and application assembly for a composition for making up and/or for the care of keratin fibres, comprising: i) a reservoir; ii) a composition for making up and/or for the care of keratin fibres, placed inside the reservoir, said composition having a threading nature dmax of greater than or equal to 5 mm; iii) a device for applying the makeup and/or care composition; and/or iv) heating means for bringing said composition, simultaneously with or subsequent to its application, to a temperature of greater than or equal to 40° C. | 01-28-2010 |
20150305991 | PROCESS FOR MAKING UP KERATIN FIBRES AND PACKAGING ASSEMBLY - The present invention relates to a cosmetic process for making up or for the non-therapeutic care of keratin fibres, comprising the application to the keratin fibres of a cosmetic composition containing at least one compound or a mixture of compounds, which, when the composition is brought to a temperature of greater than or equal to 40° C., confers on said composition a threading nature dmax of greater than or equal to 5 mm, said composition being, prior to, simultaneously with or subsequent to its application, brought to a temperature of greater than or equal to 40° C. | 10-29-2015 |
Anaïs Bezacier-Mahiet, Crest FR
Patent application number | Description | Published |
---|---|---|
20100021406 | PROCESS FOR MAKING UP KERATIN FIBRES AND PACKAGING ASSEMBLY - The present invention relates to a cosmetic process for making up or for the non-therapeutic care of keratin fibres, comprising the application to the keratin fibres of a cosmetic composition containing at least one compound or a mixture of compounds, which, when the composition is brought to a temperature of greater than or equal to 40° C., confers on said composition a threading nature dmax of greater than or equal to 5 mm, said composition being, prior to, simultaneously with or subsequent to its application, brought to a temperature of greater than or equal to 40° C. The invention also relates to a packaging and application assembly for a composition for making up and/or for the care of keratin fibres, comprising: i) a reservoir; ii) a composition for making up and/or for the care of keratin fibres, placed inside the reservoir, said composition having a threading nature dmax of greater than or equal to 5 mm; iii) a device for applying the makeup and/or care composition; and/or iv) heating means for bringing said composition, simultaneously with or subsequent to its application, to a temperature of greater than or equal to 40° C. | 01-28-2010 |
Anaïs Deplan, Echirolles FR
Patent application number | Description | Published |
---|---|---|
20160053930 | LOCK FOR A TUBULAR CONNECTION | 02-25-2016 |